Drug giant is in talks to acquire antibiotics maker Cubist for about $102 a share in cash, according to people familiar with the matter. The deal has an equity value of more than $8 billion, and could ...
Adolor stockholders will receive $4.35 cash per share and one CPR worth up to $4.50 per share, dependent on approval of opioid-associated constipation candidate. Adolor’s stock price shot up 130% this ...
ACQUISITION ADDS FIRST-IN-CLASS HOSPITAL PRODUCT ENTEREG(R)AND PROMISING LATE-STAGE COMPOUND ADL5945 LEXINGTON, Mass. & EXTON, Pa., Oct 24, 2011 (BUSINESS WIRE) -- --TRANSACTION EXPECTED TO BE ...
Michael W. Bonney to Become Non-Executive Chair of the Board of Directors Kenneth M. Bate to Become Lead Independent Director Lexington, Mass., October 20, 2014 – Cubist Pharmaceuticals, Inc. (NASDAQ: ...
The battle against emerging "superbugs" is producing a new generation of antibiotics. Now it has also produced a giant payout for a Lexington biotech on the front lines of the effort to take on ...
Cubism was one of the most influential art movements that came up in the early 20th century. Artists like Pablo Picasso and Georges Braque were the pioneers of this movement and for their time, they ...
Expands Cubist’s Leading Key Management Platform, Which Supports Companies Including Ava Labs, Everstake, Ankr, Redacted, and More Follows Cubist’s Anti-Slashing Collaboration with EigenLayer and ...
SAN DIEGO & PITTSBURGH--(BUSINESS WIRE)--Cubist Inc., a security-focused Web3 tools provider, today announced the launch of a non-custodial key management platform designed to help infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results